biomarkers to predict relapse in acute lymphoblastic leukaemia. biola m. javierre |caixaresearch '23
Published 1 month ago • 39 plays • Length 0:30Download video MP4
Download video MP3
Similar videos
-
2:05
what is a cll biomarker?
-
0:50
management of variant acute promyelocytic leukemia
-
1:08:58
nadya tarasova - dissecting cancer signaling pathways with chemical scalpels
-
1:06
mayo clinic minute: biobank patient milestone
-
2:49
improving the activity of bh3 mimetic venetoclax: a case study
-
1:17
the balance between bleeding and clotting | research in a minute | versiti
-
4:59
a novel biomarker for paediatic tumours
-
4:41
biobank | beaumont oncology clinical research
-
1:27
what is leukemia and acute lymphoplastic leukemia(all)| beinformed
-
4:23
mayo clinic biobank
-
26:25
how to use biocompatibility to evaluate changes in a medical device
-
13:50
evaluation of biocompatibility & capsular bag opacification
-
54:29
single-cell sequencing reveals clonal heterogeneity in acute lymphoblastic leukemia
-
2:23
metastatic cancer cells implode on protein contact
-
6:51
biomarker discovery solutions for lymphoma & multiple myeloma
-
14:30
a promising alternative to gold standard cytogenetic approaches in acute lymphoblastic leukemias
-
0:48
building genetic assessments into how we determine prognosis of all
-
1:25:39
the solvecfs biobank
-
6:12
introduction to visne in cytobank